Associations Between Pain, Current Tobacco Smoking, Depression, and Fibromyalgia Status Among Treatment-Seeking Chronic Pain Patients
Overview
Neurology
Psychiatry
Authors
Affiliations
Objective: As smoking impacts physiological pathways in the central nervous system, it is important to consider the association between smoking and fibromyalgia, a pain condition caused predominantly by central nervous system dysfunction. The objectives were to assess the prevalence of current smoking among treatment-seeking chronic pain patients with (FM+) and without (FM-) a fibromyalgia-like phenotype; test the individual and combined influence of smoking and fibromyalgia on pain severity and interference; and examine depression as a mediator of these processes.
Methods: Questionnaire data from 1566 patients evaluated for a range of conditions at an outpatient pain clinic were used. The 2011 Survey Criteria for Fibromyalgia were used to assess the presence of symptoms associated with fibromyalgia.
Results: Current smoking was reported by 38.7% of FM+ patients compared to 24.7% of FM- patients. FM+ smokers reported higher pain and greater interference compared to FM+ nonsmokers, FM- smokers, and FM- nonsmokers. There was no interaction between smoking and fibromyalgia. Significant indirect effects of fibromyalgia and smoking via greater depression were observed for pain severity and interference.
Conclusions: Current smoking and positive fibromyalgia status were associated with greater pain and impairment among chronic pain patients, possibly as a function of depression. Although FM+ smokers report the most negative clinical symptomatology (i.e., high pain, greater interference) smoking does not appear to have a unique association with pain or functioning in FM+ patients, rather the effect is additive. The 38.7% smoking rate in FM+ patients is high, suggesting FM+ smokers present a significant clinical challenge.
Brady J, Lapite I, Yim A, Yoo J Arthrosc Sports Med Rehabil. 2025; 7(1):101016.
PMID: 40041815 PMC: 11873478. DOI: 10.1016/j.asmr.2024.101016.
Zvolensky M, Smit T, Rogers A, Bakhshaie J, Ditre J, Rinker D J Behav Med. 2025; .
PMID: 39789403 DOI: 10.1007/s10865-024-00547-6.
Mitochondrial miRNAs and fibromyalgia: new biomarker candidates.
Rasulova K, Dilek B, Kavak D, Pehlivan M, Kizildag S Mol Biol Rep. 2024; 52(1):16.
PMID: 39589649 DOI: 10.1007/s11033-024-10110-w.
Attentional Bias for Opioids in Taiwanese Heavy Smokers with Chronic Noncancer Pain.
Liu L, Lin E, Tsao S, Wang H, Ho M Medicina (Kaunas). 2024; 60(7).
PMID: 39064536 PMC: 11279384. DOI: 10.3390/medicina60071107.
Nijs J, Malfliet A, Roose E, Lahousse A, Van Bogaert W, Johansson E J Clin Med. 2024; 13(3).
PMID: 38337338 PMC: 10855981. DOI: 10.3390/jcm13030644.